Olanzapine as a Cause of Urinary Incontinence: A Case Report

Show other versions (1)

Olanzapine, an atypical antipsychotic, is one of the most commonly used antipsychotics. Though olanzapine is commonly associated with endocrine side effects, it is generally well tolerated by most patients and is rarely associated with urinary incontinence. This report highlights the case of a 23 -...

Full description

Bibliographic Details
Published in:	Iranian Journal of Psychiatry
Main Authors:	Mobolaji Usman Dada, Lateef Olutoyin Oluwole, Patrick T Adegun, Peter O Tareo
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2012-09-01
Subjects:	Antipsychotics Enuresis Olanzapine schizophrenia Urinary incontinence
Online Access:	http://ijps.tums.ac.ir/index.php/ijps/article/view/384/318

Similar Items

Olanzapine as a cause of urinary incontinence: a case report.
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Urinary Incontinence in Elderly
by: N. S. Neki
Published: (2016-01-01)

Pediatric urinary incontinence: Classification, evaluation, and management
by: A.J. Schaeffer, et al.
Published: (2014-03-01)

Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01)

Urinary Incontinence in childhood
by: L. Szabó
Published: (2024-09-01)

Olanzapine-induced skin rash: A case report
by: Mansi Shah, et al.
Published: (2019-01-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
by: Hong Jihyung, et al.
Published: (2012-12-01)

Evaluation of the association between asthma and non-neurogenic urinary incontinence in children; a case-control study
by: Elaheh Ziaei, et al.
Published: (2023-03-01)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-05-01)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-06-01)

Sensory integration combined with interoceptive interventions for functional urinary incontinence in children: a case report
by: Lingshan Ma, et al.
Published: (2025-07-01)

One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
by: Mohammed Zain Ulabedin Adhoni, et al.
Published: (2021-10-01)

Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature
by: Andreea Teodorescu, et al.
Published: (2017-08-01)

Clozapine and urinary incontinence
by: A. Osca Oliver, et al.
Published: (2022-06-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study
by: Matsuzaki H, et al.
Published: (2021-12-01)

Is there association of olanzapine and pulmonary embolism: A case report
by: Lumin Wang, et al.
Published: (2022-06-01)

Olanzapine-associated hypothermia: a case report of a rare event
by: Manuel Monti, et al.
Published: (2018-02-01)

Olanzapine-induced bilateral pedal and pretibial edema: A case report
by: Behice Han Almis, et al.
Published: (2019-06-01)

Obsessive-Compulsive Disorders and Functional Urinary Disorders: A Fortuitous Association?
by: Qin Xiang Ng, et al.
Published: (2021-06-01)

Translational Research for Pediatric Lower Urinary Tract Dysfunction
by: Akihiro Kanematsu
Published: (2016-11-01)

Assessment of lipid response to acute olanzapine administration in healthy adults
by: Avital Nahmias, et al.
Published: (2020-04-01)

Urinary incontinence in men
by: Natalia Skierkowska, et al.
Published: (2018-07-01)

Urinary incontinence in men
by: Natalia Skierkowska, et al.
Published: (2018-07-01)

Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)

Olanzapine induced biochemical and histopathological changes after its chronic administration in rats
by: Rehmat Shah, et al.
Published: (2016-11-01)

Brazilian consensus in enuresis–recomendations for clinical practice
by: José Murillo B. Netto, et al.

Urinary Incontinence – from Childhood Onwards
by: Dragana Živković, et al.
Published: (2022-01-01)

Tunable Intranasal Polymersome Nanocarriers Triggered Olanzapine Brain Delivery and Improved In Vivo Antipsychotic Activity
by: Ahmed A. Katamesh, et al.
Published: (2025-06-01)

Pancreatitis following Olanzapine Therapy: A Report of Three Cases
by: Thomas A. Kerr, et al.
Published: (2007-06-01)

Exploring clinical and urinary factors in treatment-resistant vs. treatment-responsive childhood enuresis: a comparative study
by: Parsa Lorestani, et al.
Published: (2025-04-01)

The impact of constipation on lower urinary tract function and treatment response in patients with non-monosymptomatic enuresis
by: Yi-Ju Chou, et al.
Published: (2024-12-01)

Attenuation of Olanzapine-Induced Endoplasmic Reticulum Stress Improves Insulin Secretion in Pancreatic Beta Cells
by: Diana Grajales, et al.
Published: (2022-05-01)

Effect of metformin on olanzapine-induced weight gain: A 12-week randomised open-label study
by: G. Chetan Kumar, et al.
Published: (2025-01-01)

The use of synthetic materials in the treatment of stress urinary incontinence
by: Robert Stanek, et al.
Published: (2016-07-01)

Negative Impact of Olanzapine on ICU Delirium Resolution: An Emulated Clinical Trial
by: Ajna Hamidovic, et al.
Published: (2025-07-01)

A Review of Vesicular and Polymeric Nano-systems in Olanzapine Drug Delivery
by: Javad Setareh, et al.
Published: (2022-01-01)

The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature
by: G. Saudemont, et al.
Published: (2020-04-01)

Comparative evaluation of pancreatic histopathology of rats treated with olanzapine, risperidone and streptozocin
by: Rehmat Shah, et al.
Published: (2018-11-01)

An unusual complication of a long-acting injectable antipsychotic: deep venous thrombosis caused by olanzapine pamoate
by: Serhat Tunç, et al.
Published: (2018-04-01)